BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Canadian Pulmonary Fibrosis Foundation - ECPv6.17.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://cpff.ca
X-WR-CALDESC:Events for Canadian Pulmonary Fibrosis Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220928T133000
DTEND;TZID=America/Toronto:20220928T153000
DTSTAMP:20230207T193630Z
CREATED:20220817T163314Z
LAST-MODIFIED:20230207T193630Z
UID:10000584-1664371800-1664379000@cpff.ca
SUMMARY:Novel AI Diagnostics & Technology in PF - Colin Edwards
DESCRIPTION:Novel AI Diagnostics & Technology in PF – Colin Edwards\n\n\n\n\n\n\n\n\nLearn how novel AI diagnostics and technology help in the delivery of good healthcare and research for pulmonary fibrosis in this webinar featuring Colin Edwards. \nSpeaker Profile \nColin Edwards is Chief Scientific Officer and co-founder of patientMpower Ltd\, an Irish digital healthcare company specializing in monitoring lung and kidney health. He is responsible for the development and implementation of the clinical and health economics evaluation programme for patientMpower in respiratory (interstitial lung disease\, post-lung transplantation\, Covid19) and renal conditions (hemodialysis\, post-kidney transplantation). \nFounded Merlin Consulting Ltd in 2015 to advise creators of digital health products and develop robust assessments of the impact of new technologies on patient outcomes. \nColin was previously General Manager/Head of Medical Affairs at the Ireland affiliate of Boehringer Ingelheim. He is a member of the Institute of Directors in Ireland. \n\n\n\n\n\n\n\n\n\n\nWatch
URL:https://cpff.ca/event/novel-ai-diagnostics-technology-in-pf-colin-edwards/
CATEGORIES:Educational Forums
ATTACH;FMTTYPE=image/png:https://cpff.ca/wp-content/uploads/2022/08/Novel-AI-Diagnostics-Technology-in-PF-Colin-Edwards.png
END:VEVENT
END:VCALENDAR